Stem Solutions
| México | Turquia | Áustria | |
| Tratamento medicamentoso para a doença de Parkinson | de $1,500 | de $1,000 | de $2,000 |
| Terapia com células estaminais para a doença de Parkinson | de $5,000 | de $25,000 | de $35,000 |
| Cirurgia por Ultrassom Focado guiada por Ressonância Magnética (MRgFUS) | de $10,000 | de $10,000 | de $16,000 |
| Cirurgia de estimulação cerebral profunda (ECP) | de $17,000 | de $23,000 | de $45,000 |
| Terapia com Células Estaminais Pluripotentes Induzidas | de $5,000 | - | - |
Mais de 1.100 tratamentos realizados – O Dr. Romero é especializado em medicina regenerativa para a doença de Parkinson na Immunotherapy Regenerative Medicine.
O Dr. Eduardo Fernandez é um especialista certificado em células estaminais com reconhecimento nacional no México; aguarda a certificação internacional de sociedades prestigiadas como a ISSCR e a ISEV.
Chefe de Ensino no Hospital Regional de Puerto Vallarta, trazendo ampla liderança em educação médica para o atendimento ao paciente.
Mexico provides a full spectrum of Parkinson’s disease treatments, including gold-standard pharmacological protocols and advanced neurosurgery. Patients access deep brain stimulation (DBS) and MR-guided focused ultrasound (MRgFUS) at JCI-accredited facilities. Regenerative medicine using COFEPRIS-approved mesenchymal stem cells is also a primary option in specialized hubs.
Bookimed Expert Insight: While many seek surgery, Mexico’s real strength is the volume of regenerative medicine packages. Clinics like Rehabilitata and Aura Regenerative Center bundle 100 million stem cells with 5-star hotel stays and VIP transfers for around $5,000 to $9,500. This is significantly more comprehensive than standard clinical settings, as it integrates recovery logistics into the medical price.
Patient Consensus: Patients note that Levodopa combinations are much more affordable than in the US. However, they emphasize the importance of choosing clinics in major urban centers like Mexico City or Monterrey to ensure consistent access to English-speaking specialists.
Stem cell therapy for Parkinson’s is legal in Mexico and regulated by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS). This agency licenses clinics and approves protocols. Mexico allows cellular expansion, a process often restricted to clinical trials in the United States.
Bookimed Expert Insight: While many countries restrict regenerative medicine, Mexico possesses a unique regulatory niche for advanced cellular work. Dr. Eduardo Fernandez is one of only 50 certified stem cell experts in the country. This specialization is rare and requires passing a rigorous eight-hour examination. Choosing a doctor with this specific credential ensures your treatment follows the strictest neurological protocols available in Mexico.
Patient Consensus: Patients note that while the lack of FDA-equivalent rules feels risky, the potential for motor improvement makes the trip worth it. Many suggest informing your local neurologist beforehand to ensure you have consistent follow-up care after returning home.
Patients in Mexico report improved motor function and reduced tremors after receiving mesenchymal stem cell therapy for Parkinson's disease. Clinical outcomes often include decreased inflammatory markers like C-reactive protein. Some protocols utilizing Wharton's jelly derived cells also aim to enhance neurogenesis and neurological recovery.
Bookimed Expert Insight: While many clinics offer general regenerative care, specialized centers like Aura Regenerative Center use COFEPRIS-approved protocols. Their packages, costing around $9,500, uniquely bundle mesenchymal cells with exosome-based protocols. This combination often targets neurological disorders more specifically than standard stem cell drips found in lower-cost wellness packages.
Patient Consensus: Patients note that while physical tremors may decrease initially, these gains often diminish after 6 to 12 months. Many emphasize the need to demand objective data from clinics rather than relying on marketing testimonials.
Initial Parkinson’s interventions in Mexico typically require 5 to 14 days depending on the procedure type. Simple regenerative therapies often involve 3 to 5 days. Complex surgeries like Deep Brain Stimulation (DBS) necessitate at least 14 days for stabilization and safe air travel.
Bookimed Expert Insight: While many standard packages like those at Aura Regenerative Center include 3 hotel nights, our data shows patients often extend their stay. For neurological conditions, medication calibration and swelling checks frequently add 2 to 3 clinic visits. Choosing a clinic in Monterrey or Puerto Vallarta with on-site specialists like Dr. Ernesto Romero ensures these adjustments happen quickly without travel delays.
Patient Consensus: Patients emphasize that traveling with a companion is essential for mobility support. Many note that unexpected swelling or medication tweaks can easily turn a planned 10-day trip into 3 weeks.
Standard delivery protocols for Parkinson’s disease treatment in Mexico prioritize bypassing the blood-brain barrier to maximize cell retention. Surgeons utilize stereotactic surgery to deliver mesenchymal stem cells directly into the substantia nigra or striatum. This precise targeting often involves CT or MRI guidance to ensure high engraftment. 5-star hotel stays and VIP transfers are frequently included in treatment packages.
Bookimed Expert Insight: While many focus on the cell count, the delivery method determines the final value. At clinics like Rehabilitative Regenerative Medicine, Dr. Hernán Flores offers 100 million cell protocols via IV drip for $5,000, but specialized centers like Aura Regenerative Center charge $9,500 for neurological-specific Wharton's jelly mesenchymal stem cells. This higher price point typically reflects more complex delivery routes like intrathecal or targeted injections which are essential for neurological penetration.
Patient Consensus: Patients emphasize the importance of using imaging guidance to ensure cells reach the correct brain areas. Many survivors also mention that using mannitol or pre-injection priming helps open the blood-brain barrier for better results.
Monterrey and Puerto Vallarta are key Mexican cities hosting facilities recognized by bodies like Joint Commission International (JCI). Hospital San Jose Tecnológico de Monterrey maintains JCI accreditation for neurological care. The General Health Council of Mexico (CSG) also certifies specialized centers for regenerative protocols.
Bookimed Expert Insight: While many clinics offer general wellness, focusing on Monterrey provides a distinct advantage for Parkinson's patients. This city hosts both JCI-accredited hospitals and doctors like Dr. Hernán Flores, who leads regional medical colleges. This concentration of institutional oversight and leadership suggests a more robust infrastructure for complex neuro-regenerative care than resort-based clinics.
Patient Consensus: Patients note it is important to verify accreditation claims directly with the issuing body. They emphasize requesting long-term follow-up data specifically for Parkinson's rather than general testimonials.